New Promega Maxwell® RSC miRNA Plasma and Serum Kit Provides Quick, Automated miRNA Purification for Oncology and Translational Researchers
Madison, WI USA. (February 12, 2019)
Promega Corporation’s new Maxwell® RSC miRNA Plasma and Serum Kit offers oncology and translational researchers an easy and automated protocol to purify total circulating RNA, including miRNA, from plasma, serum and enriched exosomes for advance techniques such as NGS or ddPCR. Unlike manual miRNA purification products, the new kit is designed to be used with the Promega Maxwell® RSC and RSC 48 instruments, reducing hands-on time for researchers and providing consistent, high quality and amplifiable miRNA.
“This protocol is a real timesaver in the lab,” says Chris Moreland, Promega Global Product Manager. “The convenience of walkaway automation allows researchers to concentrate on higher valued work. Plus, the kit eliminates the need for multiple extraction protocols for researchers wanting total RNA that includes miRNA from plasma or exosomes.”
Promega introduced the Maxwell® RSC miRNA Plasma and Serum Kit to the market this week. The kit builds on the company’s growing offering of tools and technologies for oncology researchers, including the Maxwell® RSC miRNA Tissue Kit, which Promega launched in 2015.
The Maxwell® RSC miRNA Plasma and Serum Kit is not for diagnostic use. To learn more, visit: www.promega.com/miRNAPlasmaSerum.
About Promega Corporation
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 4,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.